mirtazapine has been researched along with Libman-Sacks Disease in 1 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report a 68-year-old man with systemic lupus erythematosus under treatment with immunosuppressants who developed non-HIV PML with brain lesions limited to the cerebellum and brainstem and successfully treated with a combination of mefloquine and mirtazapine." | 2.66 | Successful treatment of non-HIV progressive multifocal leukoencephalopathy: case report and literature review. ( Arai, S; Fujita, H; Hamaguchi, M; Hirata, K; Kikuchi, S; Matsuda, H; Nakamichi, K; Nakamura, T; Saijo, M; Shishido-Hara, Y; Suzuki, K; Uzuka, T, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamaguchi, M | 1 |
| Suzuki, K | 1 |
| Fujita, H | 1 |
| Uzuka, T | 1 |
| Matsuda, H | 1 |
| Shishido-Hara, Y | 1 |
| Arai, S | 1 |
| Nakamura, T | 1 |
| Kikuchi, S | 1 |
| Nakamichi, K | 1 |
| Saijo, M | 1 |
| Hirata, K | 1 |
1 review available for mirtazapine and Libman-Sacks Disease
| Article | Year |
|---|---|
Successful treatment of non-HIV progressive multifocal leukoencephalopathy: case report and literature review.
Topics: Aged; Antidepressive Agents; Antimalarials; Brain Stem; Cerebellum; Humans; Immunocompromised Host; | 2020 |